Senior insider sale
EVP, Chf Clinical Develop Offc at IONIS PHARMACEUTICALS INC — senior position signals high conviction
$925.4K
11.99K shares
What this filing means
SCHNEIDER EUGENE plans to sell 11.99K shares of IONIS PHARMACEUTICALS INC valued at approximately $925.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/19/2026ACC: 0001972481-26-000114
Officer· EVP, Chf Clinical Develop Offc
Since Dec 2020
11.99K
Shares to sell
$925.4K
Approx. market value
5.81K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Performance Stock Units
Equity Compensation
1/15/2026
5.81KTotal acquired5.81K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/15/2026 | Performance Stock Units Equity Compensation | 5.81K | — |
| Total | 5.81K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
6.18K
Market value
$512.9K
3/19/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
5.81K
Market value
$412.5K
3/19/2026
Total
Units
11.99K
Value
$925.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/19/2026 | 6.18K | $512.9K | — | Completed |
| Planned — Approximate Date | ||||
3/19/2026 | 5.81K | $412.5K | Nasdaq | Planned |
| Total | 11.99K | $925.4K | ||